Literature DB >> 18257812

Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan.

Shigeru Nakai1, Takashi Akiba, Junichiro Kazama, Keitaro Yokoyama, Masashi Fukagawa, Yoshihiro Tominaga, Kunitoshi Iseki, Yoshiharu Tsubakihara.   

Abstract

Disturbances in bone mineral metabolism are common in chronic hemodialysis (HD) patients and often underlie morbid conditions and mortality; however, no large epidemiological study for Asian dialysis patients has been performed. We analyzed the database of the Japanese Society for Dialysis Therapy registry. In this study, data from patients who were on HD at the end of 2000 was compiled. The Cox's proportional hazard analysis was carried out to evaluate the significance of the impact of variables related to bone mineral metabolism on survival after adjusting for possible confounding variables. The study period was three years, and a cohort of 27 404 HD patients was studied. The hazard ratios were 1.098 (P = 0.0129) for serum calcium levels ranging 10.0-10.9 mg/dL, and 1.243 (P = 0.0001) for serum calcium levels >11.0 mg/dL when the reference serum calcium level range was 9.0-9.9 mg/dL. Similarly, the hazard ratios were significantly higher in a serum phosphorous level of 5.0 mg/dL than for the reference serum phosphorous level range of 4.0-4.9 mg/dL. For intact parathyroid hormone (iPTH), the hazard ratios were significantly small (<119 pg/mL) when the reference iPTH level range was 180-359 pg/mL. However, the hazard ratio did not increase when the iPTH level increased to >360 pg/mL. Results showed that disturbances in bone mineral metabolism, such as those involving serum calcium, phosphorous, and iPTH, have a significant impact on survival in Japanese dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257812     DOI: 10.1111/j.1744-9987.2007.00540.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  28 in total

Review 1.  Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.

Authors:  Kamyar Kalantar-Zadeh; Anuja Shah; Uyen Duong; Rulin C Hechter; Ramanath Dukkipati; Csaba P Kovesdy
Journal:  Kidney Int Suppl       Date:  2010-08       Impact factor: 10.545

2.  Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.

Authors:  Tadao Akizawa; Ryo Kido; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Takeshi Hasegawa; Shunichi Fukuhara; Kiyoshi Kurokawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

3.  Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.

Authors:  Masahiro Yamamoto; Hiroaki Ogata; Masahide Mizobuchi; Noriyo Yoshida; Chiaki Kumata-Maeta; Fumihiko Koiwa; Kanji Shishido; Eriko Kinugasa
Journal:  Clin Exp Nephrol       Date:  2011-10-20       Impact factor: 2.801

4.  Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.

Authors:  Masafumi Fukagawa; Shingo Fukuma; Yoshihiro Onishi; Takuhiro Yamaguchi; Takeshi Hasegawa; Tadao Akizawa; Kiyoshi Kurokawa; Shunichi Fukuhara
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

Review 5.  Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients.

Authors:  Usama Feroze; Miklos Z Molnar; Ramanath Dukkipati; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

6.  Calcification of the thoracic aorta determined by three-dimensional computed tomography predicts cardiovascular complications in patients undergoing hemodialysis.

Authors:  Nozomu Kamiura; Kiyoko Yamamoto; Shioko Okada; Makoto Sakai; Akira Fujimori
Journal:  Int Urol Nephrol       Date:  2013-12-07       Impact factor: 2.370

7.  Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

Authors:  Shunsuke Goto; Hirotaka Komaba; Kensuke Moriwaki; Akira Fujimori; Koji Shibuya; Masato Nishioka; Jong-Il Kim; Kunihiko Yoshiya; Jeongsoo Shin; Hirohito Hasegawa; Masatomo Taniguchi; Hideki Fujii; Shinichi Nishi; Isao Kamae; Masafumi Fukagawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 8.237

8.  Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.

Authors:  Ramanath Dukkipati; Csaba P Kovesdy; Sara Colman; Matthew J Budoff; Allen R Nissenson; Stuart M Sprague; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2010-03-03       Impact factor: 3.655

9.  Cardiac valvular surgery in dialysis patients: comparison of surgical outcome for mechanical versus bioprosthetic valves.

Authors:  Kentaro Umezu; Satoshi Saito; Kenji Yamazaki; Akihiko Kawai; Hiromi Kurosawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-04-15

10.  Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.

Authors:  Mehdi Rambod; Csaba P Kovesdy; Rachelle Bross; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.